GSK’s long-acting injection beats Truvada in HIV prevention trial
[ad_1] (Reuters) – GlaxoSmithKline said an injection every other month of its cabotegravir drug was shown to avert an HIV
Read more
longacting
[ad_1] (Reuters) – GlaxoSmithKline said an injection every other month of its cabotegravir drug was shown to avert an HIV
Read more